FDA/acc (@thinkbynumbers) header
FDA/acc (@thinkbynumbers) profile picture

Trade one apocalypse for disease eradication at https://nitter.gq/t.co/rE1rNd5o4d

St Louis, MO
Joined November 2009
Photo by FDA/acc (@thinkbynumbers)Photo by FDA/acc (@thinkbynumbers)Photo by FDA/acc (@thinkbynumbers)Photo by FDA/acc (@thinkbynumbers)Photo by FDA/acc (@thinkbynumbers)Photo by FDA/acc (@thinkbynumbers)Photo by FDA/acc (@thinkbynumbers)Photo by FDA/acc (@thinkbynumbers)Photo by FDA/acc (@thinkbynumbers)Photo by FDA/acc (@thinkbynumbers)
For my first post, I’m sharing a letter @NVIDIA signed on why open models matter. AI will transform every industry, power every company, and be built by every country. Open models strengthen safety and cybersecurity, accelerate innovation and diffusion, and enable sovereignty. The world needs both frontier closed models and frontier open models. images.nvidia.com/pdf/Open-W…
16,564
34,466
12,076
193,868
69,436,281
Narrator: they did not get to work.
152
6,115
59
75,701
682,647
Infinita is proudly declaring its support for the "Faster Clinical Trials Act", a bipartisan bill introduced by Reps. @JakeAuch (D-MA) and @RepMGriffith (R-VA). Clinical trial reform at the federal level has suffered from a lack of ambition. This is the first bill that I've seen that is not lacking ambition whatsoever. "The bill also sets targets to reduce the cost per patient for the clinical trials conducted by these networks by 30 to 50 percent and speed participant enrollment in those trials by 30 percent." The mechanisms how to reduce costs are a distillation best policy research that I've seen over the years, incl. by @IFP, @RuxandraTeslo, @sytses & many more The things I am most excited about: - Bringing evidence generation closer into the clinic; proving real-world effectiveness has been an afterthought in FDA approvals, leading to lack of safety & efficacy - Streamlined trial site networks that can be accessed via a "multi-site, single-IRB", overcoming the IRB fragmentation that is a major source of delay in early research - Governance sandboxes - critically, the bill does not make the mistake of trying to fix everything at once. Its mandate is to support sandboxes, innovative trial models With this, the US has a real shot at retaining its competitive advantage in biotech, and could do right by millions of patients to access trials in the US instead of abroad.
3
11
5
52
3,408
I’d like to report the Federal Reserve
See fraud? It's time to expose it. Report fraud, waste, and abuse to the federal government 📲 America.gov/fraud
149
993
46
6,202
52,764
Computer scientist Sara Hooker on underestimating difficulty:
55
2,161
136
21,037
400,869
It feels like a failure. Maybe it is. I am sunsetting DeSci Reviews: an experiment with a negative result. In science, a negative result is still a result. So I’m reporting this one the way I’d report any other.
10
5
4
53
2,071
Socialists discovered that corporations have too much power and proposed merging your employer, landlord and grocery store into one institution with a police force and military.
109
1,157
70
12,055
238,370
This framing assumes over prioritising safety has no downside. It means telling a stage 4 cancer patient they can’t take a drug that passed a phase 3 trial, and must die of their cancer instead, while experts debate how it works. It’s their body and their choice. For that patient the choice isn’t wait safely vs take a risky drug. It’s die waiting vs a chance of living. That’s why patients already inject untested compounds at unregulated clinics in Mexico. Millions die while we wait and nobody gets blamed. If 100 people died from an AI designed drug it would be called a catastrophe, even though most of them would have been dead within months anyway. Patients know new drugs can go wrong. The alternative is extreme suffering or death. We aren’t impatient because we want the next shiny update, we’re impatient because many of us will die before it arrives. Drug regulation is already too strict. With AI now moving biology this fast, the priority should be loosening it, not tightening it. Right now a patient who will die from their disease in a few months, or take their own life because of the suffering, usually can’t get access to promising drugs still in trials or try combinations that might work better together but carry more side effect risk. They just have to die. If we were being logical, those patients could enroll in a program, try the drug or any combination they want, and record the outcome so it feeds back into the science. Relying on slow, admin heavy trials with tightly selected groups as the only way to learn about new treatments is the least efficient and least ethical option we have. It exists to protect pharma and regulators from blame, not to reduce suffering and death. Now that some people could realistically be cured in the next decade instead of waiting 20 years for trial funding and long term outcome studies, we should be moving away from it fast. For weight loss or baldness, be as rigorous as you like. Framing this around stage 4 cancer is detached from what patients actually face. The people debating it don’t pay for the delay, the patient does.
This is a slide from Terence Tao's 'Math 2.0' public lecture yesterday evening at Caltech. I am highly confident that, if the cure actually worked, almost any Stage 4 cancer patient would tell you that human comprehension of its mechanism is completely irrelevant to them.
14
10
3
89
4,665
Replying to @Daniell64334313
Scientific data does show a notable, population-wide shift in human behavior and personality traits following the pandemic. Here are two prominent studies for your review, plus the Pew Research Center Study, thrown in for extra measure. 1. The FSU College of Medicine "Pandemic Personality" Study The Findings: The study found statistically significant population-wide declines in Agreeableness (the capacity for empathy, trust, sympathy, and cooperation) and Extraversion (sociability and the desire to seek out others' company) by 2021/2022. The shifts were so severe that researchers stated the population experienced the equivalent of a decade of normal personality alteration compressed into just two years. Younger adults were hit hardest, showing sharp increases in neuroticism paired with a steep drop in overall friendliness and compliance with social norms. 2. The College Student Cognitive Empathy Study. The Study: Published in the Journal of American College Health (2022), this longitudinal study tracked college students' psychological well-being and empathic capacity immediately before and during the pandemic phases. The Findings: The researchers observed a significant decline in cognitive empathy (the psychological capacity to take another person's perspective or understand their mental and emotional state). This degradation of perspective-taking directly mirrors the "colder" and more "detached" behavior observed in the general public, as individuals became structurally less capable of processing or caring about the experiences of those around them while battling their own chronic stress and isolation. The Pew Research Center also reveals that 47% of American adults explicitly report that public human behavior became significantly ruder and more aggressive since the onset of the pandemic.
7
98
11
472
37,191
FDA/acc retweeted
If you want to understand why healthcare is so expensive, I'd start with a Supreme Court case about teeth whitening. Around 2003, spas and small kiosks in North Carolina were offering teeth whitening for a fraction of what dentists charge. So dentists complained to the state dental board. That dental board looks like this: - 6 of 8 are practicing dentists, elected by other dentists - 8 of the 10 who sat on the board during this period earned substantial fees from whitening The board sent 47+ cease-and-desist letters, warning non-dentists that they're committing a crime by practicing dentistry without a license. The board also sent letters to mall operators, advising them to expel whitening kiosks. All this worked! These kiosks shut down, prices stayed high, dentists stayed happy. Regulatory capture like this exists all over in healthcare. What makes this case notable is that someone actually sued the NC dental board, in a case that went all the way to the supreme court. In a 6-3 ruling, the SC ruled that if a board is run by those who participate in the market without proper supervision - that looks like a cartel, therefore, antitrust law applies. I have to believe there are so many other potential cases like this in healthcare, just waiting to be pressed on. I'd love to see more of this.
146
1,122
68
7,747
316,461
FDA approval does not prove a drug works. That's a myth. There is a difference between efficacy and effectiveness: - Efficacy = the drug beat placebo in a trial. A technical term. It's what FDA approval certifies. - Effectiveness = the drug works in the real patient population And there is a well-studied gap between efficacy and effectiveness.
7
28
2,042
FDA/acc retweeted
Science Alert: 'Brain Scans of 24 People With Long COVID Reveal Signs of Injury to Dopamine Neurons' "Our findings provide compelling evidence that long COVID involves the loss of dopamine-releasing neurons" sciencealert.com/brain-scans…
15
167
12
493
11,092
FDA/acc retweeted
Have you taken notice of how America makes the people that it claims to "liberate" suffer immensely? Remember the 500,000 dead Iraq children (from sanctions) that America's U.S. Ambassador to the UN said was "worth it"? Then came the invasion of that same country. Iraq had nothing to do with 9/11 and that had no WMD's! Or how about the poor Cuban people that are suffering immensely (right now) from the blockade of Cuba? How about the Iranian people, who are added to the list of those who suffer from America's invasion, blockade and sanctions? It's never about "liberation" or "freedom." How can it be, when the very same people take away as many freedoms of OURS that they possibly can? Watch @RonPaul & @ChrisRossini below:
22
358
15
1,414
40,464
Today is International Longevity Day. At Lifespan Research Institute, we’re working toward a future where growing older doesn’t have to mean an ever-increasing burden of disease. That future won’t come from a single discovery. It takes an ecosystem. At LRI, we work across that ecosystem to drive the field forward on multiple fronts: 📰 Educating through thousands of articles and resources 📈 Catalyzing millions in longevity biotech investment 🔬 Translating research toward the clinic 🤝 Building tools, advocacy & collaborations With your support, we can do even more, from expanding our Rejuvenation Roadmap and advancing therapies targeting mitochondrial dysfunction and senescent cells, to developing digital biomarkers that can help us better measure human aging and building the connections that turn promising science into real-world impact. At a time when the future is so often defined by what may go wrong, we believe it’s worth investing in what can go right. If you believe a healthier future is worth building, stand with LRI this International Longevity Day. 💙 Support our work: lifespan.io/support We welcome one-time and recurring donations, gifts of stock, cryptocurrency, and through donor-advised funds. For larger gifts or matching support, please contact [email protected] #InternationalLongevityDay #LongevityResearch #HealthyLongevity
5
16
1,024
A subset of people diagnosed with severe psychiatric illnesses may actually have immune-mediated brain diseases. Properly diagnosing and effectively treating these patients is an important area of discovery in the mental health space. I had a deeply interesting and informative time visiting researchers at the National Institute of Mental Health yesterday, who are working on cutting-edge approaches to that issue and many more.
117
201
47
1,094
62,361
33
912
25
4,840
40,696
FDA/acc retweeted
Economist @JohnHCochrane joined us to break down 3 ideas on healthcare regulation: - The poor need protection - Patients lack the information to choose well - People in a health crisis can't shop around
4
4
8
1,893
FDA/acc retweeted
The tell was always what both parties agreed on. Not what they fought about. What they agreed on. They fought about abortion. They agreed on the military budget. They fought about immigration. They agreed on Wall Street deregulation. They fought about trans athletes. They agreed on not taxing unrealized capital gains. They fought about Dr. Seuss. They agreed on drone warfare. They fought about cancel culture. They agreed on the surveillance architecture built after 2001 that has never been dismantled. The fights were loud, personal, morally charged, identity-coded, and covered wall to wall. The agreements were made in committee, in legislative language nobody reads, in budget line items, in appointments to regulatory agencies whose names most voters couldn't name. Democracy, in this arrangement, is the performance of disagreement about the things that don't threaten the arrangement. The things that threaten the arrangement are handled through the bipartisan consensus that the performance is specifically designed to make invisible. Watch what they agree on. Everything else is theater with a very large production budget.
43
642
48
1,468
24,210
FDA/acc retweeted
Both Parties Offer Us Different Variations of Socialism Both are against free markets.
251
1,306
126
6,047
260,721